The impact of genetic information on the insurance industry: Conclusions from the 'bottom-up' modelling programme

ASTIN Bulletin

Volumn 41, Issue 2, 2011, Pages 343-376

  Macdonald, Angus ^a   Yu, Fei ^a  

^a HERIOT WATT UNIVERSITY   (United Kingdom)

Author keywords

Adverse selection; Critical illness insurance; Family history; Genetic tests; Life insurance; Single gene disorder

Indexed keywords

EID: 84855160939     PISSN: 05150361     EISSN: 17831350     Source Type: Journal    
DOI: 10.2143/AST.41.2.2136981     Document Type: Article

References (49)

1. BELL, J. (1947) Dystrophia myotonic and allied diseases, in Treasury of Human Inheritance 4, Part V, ed. Penrose, L.S., Cambridge University Press, Cambridge.
2. BOUCHARD, G., ROY, R., DECLOS, M., KOULADJIAN, K. and MATHIEU, J. (1988) Spreading of the gene for myotonic dystrophy in Saguenay (Quebec). Journal de Génétique Humaine 36, 221-237.
3. BRACKENRIDGE, R. and ELDER, J. (1998) Medical Selection of Life Risks 4th edition. Macmillan, New York.
4. ESPINOSA, C. and MACDONALD, A.S. (2007) A correction for ascertainment bias in estimating rates of onset of highly penetrant genetic disorders. ASTIN Bulletin, 37, 429-452.
5. FORD, C., KIDD, A. and HAMMOND-TOOKE, G. (2006) Myotonic dystrophy in Otago, New Zealand. New Zealand Medical Journal, 119, U2145
6. FROHOCK, A.M. (2003) The CTG expansion mutation in myotonic dystrophy: Genotype-phenotype comparisons and the relevance to insurance. Final Year Honours Project. Unpublished dissertation, University of Nottingham.
7. GRIMM, T. (1975) Myotonic dystrophy. Ph.D. Thesis. University of Göttingen.
8. GUI, E.H. (2003) Modelling the impact of genetic testing on insurance - Early-onset Alzheimer's disease and other single-gene disorders. Ph.D Thesis. Heriot-Watt University.
9. GUI, E.H. and MACDONALD, A.S. (2002) A Nelson-Aalen estimate of the incidence rates of early-onset Alzheimer's disease associated with the Presenilin-1 gene. ASTIN Bulletin, 32, 1-42.
10. GUI, E.H., LU, B., MACDONALD, A.S., WATERS, H.R. and WEKWETE, C. (2006) The genetics of breast and ovarian cancer III: A new model of family history with insurance applications. Scandinavian Actuarial Journal, 2006, 338-367.
11. GUTIÉRREZ, C. and MACDONALD, A.S. (2003) Adult polycystic kidney disease and critical illness insurance. North American Actuarial Journal, 7, 93-115.
12. GUTIÉRREZ, C. and MACDONALD, A.S. (2004) Huntington's disease, critical illness insurance and life insurance. Scandinavian Actuarial Journal, 2004, 279-313.
13. GUTIÉRREZ, C. and MACDONALD, A.S. (2007) Adult polycystic kidney disease and insurance: A case study in genetic heterogeneity. North American Actuarial Journal, 11, 90-118.
14. HARPER, P.S. (1973) Pre-symptomatic detection and genetic counselling in myotonic dystrophy. Clinical Genetics, 4, 134-140.
15. HARPER, P.S. (1996) Huntington's Disease. WB Saunders, London.
16. HARPER, P.S. (2001) Myotonic Dystrophy. WB Saunders, London.
17. HGAC (1997) The implications of genetic testing for insurance. Human Genetics Advisory Commission, London.
18. HGC (2000) Whose hands on your genes? Human Genetics Commission, London.
19. HODGE, S.E. (2002) Ascertainment, in Biostatistical genetics and genetic epidemiology, eds. Elston, R., Olson, J. & Palmer, L. John Wiley.
20. HÖWELER, C.J. (1986) A clinical and genetic study in myotonic dystrophy. PhD Thesis. University of Rotterdam.
21. HSIAO, K.M., CHEN, S.S., LI, S.Y., CHIANG, S.Y., LIN, H.M., PAN, H., HUANG, C.C., KUO, H.C., JOU, S.B., SU, C.C., RO, L.S., LIU, C.S., LO, M.C., CHEN, C.M. and LIN, C.C. (2003) Epidemiological and genetic studies of myotonic dystrophy type 1 in Taiwan. Neuroepidemiology, 22, 283-289. (Pubitemid 36993909)
22. KLEIN, D. (1958) La dystrophie myotonique (Steinert) et la myotonie congénitale (Thomsen) en Suisse: étude clinique, génétique et démographique. Journal de Géné tique Humaine, 7 SUPPL, 1-328.
23. LÓPEZ DE MUNAIN, A., EMPARANZA, J.I., POZA, J.J., MARTÍ MASSÓ, J.F., COBO, A., MARTORELL, L., BAIGET, M. and MARTÍNEZ LAGE, J.M. (1993) Prevalence of myotonic dystrophy in Guipúzcoa (Basque Country, Spain). Neurology, 43, 1573-1576.
24. LU, L., MACDONALD, A.S., WATERS, H.R. and YU, F. (2007) A dynamic family history model of hereditary nonpolyposis colorectal cancer and critical illness insurance. Annals of Actuarial Science, 2, 289-325.
25. MACCALMAN, L. (2009) Effects of genetic testing on insurance: Pedigree analysis and ascertainment adjustment. Ph.D Thesis. Heriot-Watt University.
26. MACDONALD, A.S. (1997) How will improved forecasts of individual lifetimes affect underwriting? British Actuarial Journal, 3, 1044-1058.
27. MACDONALD, A.S. (1999) Modelling the impact of genetics on insurance. North American Actuarial Journal, 3, 83-101.
28. MACDONALD, A.S. (2003a) Genetics and insurance: What we have learned so far? Scandinavian Actuarial Journal, 2003, 324-328.
29. MACDONALD, A.S. (2003b) Moratoria on the use of genetic tests and family history for mortgagerelated life insurance. British Actuarial Journal, 9, 279-311.
30. MACDONALD, A.S., WATERS, H.R. and WEKWETE, C.T. (2003a) The genetics of breast and ovarian cancer I: A model of family history. Scandinavian Actuarial Journal, 2003, 1-27.
31. MACDONALD, A.S., WATERS, H.R. and WEKWETE, C.T. (2003b) The genetics of breast and ovarian cancer II: A model of critical insurance. Scandinavian Actuarial Journal, 2003, 28-50.
32. MACDONALD, A.S. and TAPADAR, P. (2010) Multifactorial genetic disorders and adverse selection: Epidemiology meets economics. Journal of Risk and Insurance, 77(1), 155-182.
33. MACDONALD, A.S. and YU, F. (2010) How will screening for genetic disorders affect insurance?: A case study of colorectal cancer. Submitted.
34. MACMILLAN, J.C., and HARPER, P.S. (1991) Single-gene neurological disorders in South Wales: an epidemiological study. Annals of Neurology, 30, 411-414.
35. MAGEE, A. and NEVIN, N.C. (1999) The epidemiology of myotonic dystrophy in Northern Ireland. Community Genetics, 2, 179-183. (Pubitemid 30415623)
36. MATHIEU, J., BRAEKELEER, M. and PRÉVOST, C. (1990) Genealogical reconstruction of myotonic dystrophy in the Saguenay-Lac-Saint-Jean area (Quebec, Canada). Neurology, 40, 839-842. (Pubitemid 20159628)
37. MEDICA, I., MARKOVIC, D., and PETERLIN, B. (1997) Genetic epidemiology of myotonic dystrophy in Istria, Croatia. Acta Neurologica Scandinavica, 95(3), 164-166. (Pubitemid 27149405)
38. MLADENOVIC, J., PEKMEZOVIC, T., TODOROVIC, S., RAKOCEVIC-STOJANOVIC, V., ROMAC, S. and APOSTOLSKI, S. (2005) Epidemiology of myotonic dystrophy type 1 in the population of central Serbia. Vojnosanitetski pregled, 62, 377-382.
39. MLADENOVIC, J., PEKMEZOVIC, T., TODOROVIC, S., RAKOCEVIC-STOJANOVIC, V., SAVIC, D., ROMAC, S., and APOSTOLSKI, S. (2006) Survival and mortality of myotonic dystrophy type 1 (Steinert's disease) in the population of Belgrade. European Journal of Neurology, 13, 451-454. (Pubitemid 43823357)
40. MOR-COHEN, R., MAGAL, N., GADOTH, N., ACHIRON, A., SHOHAT, T. and SHOHAT, M. (1997) The lower incidence of myotonic dystrophy in Ashkenazic Jews compared to North African Jews is associated with a significantly lower number of CTG trinucleotide repeats. Israeli Journal of Medical Science, 33, 190-193. (Pubitemid 27410090)
41. MOSTACCIULOL, M.L., BARBUJANI, G., ARMANI, M., DANIELI, G.A. and ANGELINI, C. (1987) Genetic epidemiology of myotonic dystrophy. Genetic Epidemiology, 4, 289-298. (Pubitemid 17142430)
42. NESTEROV, L.N., SUSHCHEVA, G.P., VIATKINA, S., and NESTEROVA, I. (1983) Myotonic Dystrophy. Zh Nevropatol Psikhiatr Im S S Korsakova, 83, 1634-1641.
43. OSAME, M. and FURUSHO, T. (1983) Genetic epidemiology of myotonic dystrophy in Kagoshima and Okinawa districts in Japan. Rinsho Shinkeigaku, 23, 1067-1071. (Pubitemid 14167427)
44. PATERNAK, J.J. (1999) Human molecular genetics. Fitzgerald Science Press, Bethesda MD.
45. RAEBURN, A.J. (2000) Evidence given to the Human Genetics Commission. www.hgc.gov.uk/client/Content-wide.asp?ContentId=670, accessed on 20 May 2010.
46. SICILIANO, G., MANCA, M., GENNARELLI, M., ANGELINI, C., ROCCHI, A., IUDICE, A., MIORIN, M. and MOSTACCIULOL, M. (2001) Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis. Clinical Genetics, 59, 344-349. (Pubitemid 32451973)
47. THOMASEN, E. (1948) Myotonia. Universitetsforlaget.
48. WILKIE, A.D. (2000) Report by the independent actuary on the application by the Association of British Insurers to the Genetics and Insurance Committee for approval to use genetic test results for insurance risk assessment - use of Huntington's disease test in life insurance. Genetics and Insurance Committee, Department of Health, London.
49. YU, F. (2010) The financial impact of genetic information on the insurance industry. Ph.D Thesis. Heriot-Watt University.